The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Follow-up strategies for women treated for early breast cancer
Open accessAbstract
BACKGROUND: Follow-up examinations are commonly performed after primary treatment for women with breast cancer. They are used to detect recurrences at an early (asymptomatic) stage. This is an update of a Cochrane review first published in 2000. OBJECTIVES: To assess the effectiveness of different policies of follow-up for distant metastases on mortality, morbidity and quality of life in women treated for stage I, II or III breast cancer. SEARCH METHODS: For this 2014 review update, we searched the Cochrane Breast Cancer Group's Specialised Register (4 July 2014), MEDLINE (4 July 2014), Embase (4 July 2014), CENTRAL (2014, Issue 3), the World Health Organization (WHO) International Clinical Trials Registry Platform (4 July 2014) and ClinicalTrials.gov (4 July 2014). References from retrieved articles were also checked. SELECTION CRITERIA: All randomised controlled trials (RCTs) assessing the effectiveness of different policies of follow-up after primary treatment were reviewed for inclusion. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trials for eligibility for inclusion in the review and risk of bias. Data were pooled in an individual patient data meta-analysis for the two RCTs testing the effectiveness of different follow-up schemes. Subgroup analyses were conducted by age, tumour size and lymph node status. MAIN RESULTS: Since 2000, one new trial has been published; the updated review now includes five RCTs involving 4023 women with breast cancer (clinical stage I, II or III).Two trials involving 2563 women compared follow-up based on clinical visits and mammography with a more intensive scheme including radiological and laboratory tests. After pooling the data, no significant differences in overall survival (hazard ratio (HR) 0.98, 95% confidence interval (CI) 0.84 to 1.15, two studies, 2563 participants, high-quality evidence), or disease-free survival (HR 0.84, 95% CI 0.71 to 1.00, two studies, 2563 participants, low-quality evidence) emerged. No differences in overall survival and disease-free survival emerged in subgroup analyses according to patient age, tumour size and lymph node status before primary treatment. In 1999, 10-year follow-up data became available for one trial of these trials, and no significant differences in overall survival were found. No difference was noted in quality of life measures (one study, 639 participants, high-quality evidence).The new included trial, together with a previously included trial involving 1264 women compared follow-up performed by a hospital-based specialist versus follow-up performed by general practitioners. No significant differences were noted in overall survival (HR 1.07, 95% CI 0.64 to 1.78, one study, 968 participants, moderate-quality evidence), time to detection of recurrence (HR 1.06, 95% CI 0.76 to 1.47, two studies, 1264 participants, moderate-quality evidence), and quality of life (one study, 356 participants, high-quality evidence). Patient satisfaction was greater among patients treated by general practitioners. One RCT involving 196 women compared regularly scheduled follow-up visits versus less frequent visits restricted to the time of mammography. No significant differences emerged in interim use of telephone and frequency of general practitioners's consultations. AUTHORS' CONCLUSIONS: This updated review of RCTs conducted almost 20 years ago suggests that follow-up programs based on regular physical examinations and yearly mammography alone are as effective as more intensive approaches based on regular performance of laboratory and instrumental tests in terms of timeliness of recurrence detection, overall survival and quality of life.In two RCTs, follow-up care performed by trained and not trained general practitioners working in an organised practice setting had comparable effectiveness to that delivered by hospital-based specialists in terms of overall survival, recurrence detection, and quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Self-citationCochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,263
Goldhirsch, A., Winer, E. P., Coates, A. S., Gelber, R. D., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J., Albain, K. S., André, F., Bergh, J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt303 · Cited by 3,746
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,842
Metastatic Behavior of Breast Cancer Subtypes
Kennecke, H., Yerushalmi, R., Woods, R., Cheang, M. C. U., Voduc, D., Speers, C. H., Nielsen, T. O., & Gelmon, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9820 · Cited by 2,262
Cherniss, H. F., & Chern, S.-S. (1989) · Cited by 1,373
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Bast, R. C., Ravdin, P., Hayes, D. F., Bates, S., Fritsche, H., Jessup, J. M., Kemeny, N., Locker, G. Y., Mennel, R. G., & Somerfield, M. R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1865 · Cited by 879
Khatcheressian, J. L., Hurley, P., Bantug, E., Esserman, L. J., Grunfeld, E., Halberg, F., Hantel, A., Henry, N. L., Muss, H. B., Smith, T. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.9859 · Cited by 626
Grunfeld, E., Levine, M. N., Julian, J. A., Coyle, D., Szechtman, B., Mirsky, D., Verma, S., Dent, S., Sawka, C., Pritchard, K. I., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2235 · Cited by 540
Circulating tumour cells in non-metastatic breast cancer: a prospective study
Lucci, A., Hall, C. S., Lodhi, A. K., Bhattacharyya, A., Anderson, A. E., Xiao, L., Bedrosian, I., Kuerer, H. M., & Krishnamurthy, S. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70209-7 · Cited by 507
Intensive Diagnostic Follow-up After Treatment of Primary Breast Cancer: A Randomized Trial
Del Turco, M. R. (1994) · JAMA · doi:10.1001/jama.1994.03510440053032 · Cited by 497
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Senkus, E., Kyriakides, S., Penault-Llorca, F., Poortmans, P., Thompson, A., Zackrisson, S., & Cardoso, F. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt284 · Cited by 479
Routine follow up of breast cancer in primary care: randomised trial
Grunfeld, E., Mant, D., Yudkin, P., Adewuyi-Dalton, R., Cole, D., Stewart, J., Fitzpatrick, R., & Vessey, M. (1996) · BMJ · doi:10.1136/bmj.313.7058.665 · Cited by 401
Metzger-Filho, O., Sun, Z., Viale, G., Price, K. N., Crivellari, D., Snyder, R. D., Gelber, R. D., Castiglione-Gertsch, M., Coates, A. S., Goldhirsch, A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.1574 · Cited by 343
Duffy, S. W., Nagtegaal, I. D., Wallis, M., Cafferty, F. H., Houssami, N., Warwick, J., Allgood, P. C., Kearins, O., Tappenden, N., O'Sullivan, E., et al. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn120 · Cited by 279
Grunfeld, E., Fitzpatrick, R. M., Mant, D., Yudkin, P. L., Adewuyi-Dalton, R., Stewart, J., Cole, D., & Vessey, M. P. (1999) · Europe PMC (PubMed Central) · Cited by 257
Smith, T. J., Davidson, N. E., Schapira, D. V., Grunfeld, E., Muss, H. B., Vogel, V. G., & Somerfield, M. R. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1080 · Cited by 252
Primary Care for Survivors of Breast Cancer
Burstein, H. J., & Winer, E. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010123431506 · Cited by 241
Breast Cancer Adjuvant Therapy: Time to Consider Its Time-Dependent Effects
Jatoi, I., Anderson, W. F., Jeong, J.-H., & Redmond, C. K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.3550 · Cited by 172
Can We Cure Limited Metastatic Breast Cancer?
Hortobágyi, G. N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.620 · Cited by 146
Follow-up strategies for women treated for early breast cancer
Rojas, M., Telaro, E., Russo, A., Fossati, R., Palli, D., Rosselli, T. M. D., Confalonieri, C., & Liberati, A. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001768 · Cited by 140
Self-citationGulliford, T., Opomu, M., Wilson, E. M., Hanham, I. W. F., & Epstein, R. J. (1997) · BMJ · doi:10.1136/bmj.314.7075.174 · Cited by 138
McCrory, P. R., Bladin, P. F., & Berkovic, S. F. (1997) · BMJ · doi:10.1136/bmj.314.7075.171 · Cited by 134
Population-Based Longitudinal Study of Follow-Up Care for Breast Cancer Survivors
Grunfeld, E., Hodgson, D. C., Giudice, M. E. D., & Moineddin, R. (2010) · Journal of Oncology Practice · doi:10.1200/jop.200009 · Cited by 134
Follow-up strategies for women treated for early breast cancer
Rojas, M. P. M., Telaro, E., Moschetti, I., et al. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001768.pub2 · Cited by 128
Self-citationElkins, M. R., & Moseley, A. M. (2015) · Journal of Physiotherapy · doi:10.1016/j.jphys.2015.05.013 · Cited by 122
Kobayashi, T., Ichiba, T., Sakuyama, T., Arakawa, Y., Nagasaki, E., Aiba, K., Nogi, H., Kawase, K., Takeyama, H., Toriumi, Y., et al. (2012) · Breast Cancer · doi:10.1007/s12282-012-0347-0 · Cited by 120
Pestalozzi, B. C., Luporsi, É., Jost, L. M., & Bergh, J. C. S. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi825 · Cited by 92
Follow-up after treatment of primary breast cancer
Rutgers, E. J. T., van Slooten, E. A., & Kluck, H. M. (1989) · British journal of surgery · doi:10.1002/bjs.1800760227 · Cited by 84
Breast cancer in women ≤35 years: Review of 1002 cases from a single institution
Chan, A., Pintilie, M., Vallis, K. A., Girourd, C., & Goss, P. E. (2000) · Annals of Oncology · doi:10.1023/a:1008391401404 · Cited by 76
Sisler, J. J., Chaput, G., SUSSMAN, J. S., & Ozokwelu, E. (2016) · PubMed · Cited by 71
Follow-up of patients with early breast cancer: Is it time to rewrite the story?
Puglisi, F., Fontanella, C., Numico, G., Sini, V., Evangelista, L., Monetti, F., Gori, S., & Mastro, L. D. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.03.001 · Cited by 44
Nicolini, A., Carpi, A., Michelassi, C., Spinelli, C., Conte, M., Miccoli, P., Fini, M., & Giardino, R. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.09.004 · Cited by 32
Dixon, J. M., & Montgomery, D. (2008) · BMJ · doi:10.1136/bmj.39421.440799.be · Cited by 32
(2005) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(05)86135-6 · Cited by 13
GUIDELINES FOR THE SURGICAL MANAGEMENT OF BREAST CANCER
Collins, J. P., & Simpson, J. S. (1997) · Australian and New Zealand Journal of Surgery · Cited by 10
Research works printed but not linked: 20
- Carlotti, 1993, The mammographic images of the irradiated breast after conservative therapy for carcinoma, La Radiologia Medica, 86, 101
- Chopra, 2014, Follow-up care for breast cancer survivors: improving patient outcomes, Patient Related Outcome Measures, 30, 71, 10.2147/PROM.S49586 · doi:10.2147/prom.s49586
- Constantinidou, 2011, Positron emission tomography/computed tomography in the management of recurrent/metastatic breast cancer: a large retrospective study from the Royal Marsden Hospital, Annals of Oncology, 22, 307-14, 10.1093/annonc/mdq343 · doi:10.1093/annonc/mdq343
- Grandjean, 2012, Evaluation of the adherence to follow-up care guidelines for women with breast cancer, European Journal of Oncology Nursing, 16, 281, 10.1016/j.ejon.2011.07.004 · doi:10.1016/j.ejon.2011.07.004
- Greco, 1998, Impact of the diagnostic methods on the therapeutics strategies, The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 42, 66
- Grunfeld, 1999, Comparison of breast cancer patient satisfaction with follow-up in primary care vs specialist care: results from a randomized controlled trial, British Journal of Clinical Practice, 49, 705
- Hannisdal, 1993, Follow-up of breast cancer patients stage I-II: A baseline strategy, European Journal of Cancer, 29A, 992, 10.1016/S0959-8049(05)80208-4 · doi:10.1016/s0959-8049(05)80208-4
- Harries, 1996, A survey of the management of breast cancer in England and Wales, Annals of the Royal College of Surgeons of England, 78, 197
- Hietanen, 1986, Chest radiography in the follow-up of breast cancer, Acta Radiologica Oncology, 25, 15, 10.3109/02841868609136370 · doi:10.3109/02841868609136370
- Holli, 1998, Effect of radiotherapy on the interpretation of routine follow-up mammography after conservative breast surgery: a randomised study, British Journal of Cancer, 78, 542, 10.1038/bjc.1998.529 · doi:10.1038/bjc.1998.529
- Logarer, 1990, The limited value of routine chest X-ray in the follow-up of stage II breast cancer, European Journal of Cancer, 26, 553, 10.1016/0277-5379(90)90073-3 · doi:10.1016/0277-5379(90)90073-3
- Loprinzi, 1994, It is now the age to define the appropriate follow-up of primary breast cancer patients [editorial], Journal of Clinical Oncology, 12, 881, 10.1200/JCO.1994.12.5.881 · doi:10.1200/jco.1994.12.5.881
- Mahoney, 1986, Methods for detecting locally recurrent and controlateral second primary breast cancer, Canadian Journal of Surgery, 29, 372
- Margenthaler, 2012, Surveillance of patients with breast cancer after curative-intent primary treatment: current practice patterns, Journal of Oncology Practice, 8, 79, 10.1200/JOP.2011.000289 · doi:10.1200/jop.2011.000289
- Pandya, 1983, Frequency and patterns of early disease recurrence and method of detection in operable breast cancer with pathologically positive axillary lymph nodes on Eastern Cooperative Oncology Group Adjuvant studies: A preliminary report, Cancer Treatment Symposium, 2, 117
- The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014
- Stark, 1996 Jun, Breast cancer evaluation and follow-up: a survey of The Ohio Chapter of The American College of Surgeons, American Surgeon, 62, 458
- Tomiak, 1998, Follow-up practices for patients with early stage breast cancer: a survey of Canadian oncologists, Cancer Prevention & Control, 2, 63
- Vestergaard, 1989, The value of yearly chest x-ray in patients with stage I breast cancer, European Journal of Cancer and Clinical Oncology, 25, 687, 10.1016/0277-5379(89)90205-8 · doi:10.1016/0277-5379(89)90205-8
- Wickerham, 1984, The efficacy of bone scanning in the follow-up of patients with operable breast cancer, Breast Cancer Research and Treatment, 4, 303, 10.1007/BF01806043 · doi:10.1007/bf01806043
Cited by
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Loibl, S., André, F., Bachelot, T., Barrios, C. H., Bergh, J., Burstein, H. J., Cardoso, M. J., Carey, L. A., Dawood, S., Del Mastro, L., et al. (2024) · Annals of Oncology · doi:10.1016/j.annonc.2023.11.016 · Cited by 1,008
Schnipper, L. E., Smith, T. J., Raghavan, D., Blayney, D. W., Ganz, P. A., Mulvey, T. M., & Wollins, D. S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.8375 · Cited by 649
Follow-up strategies for patients treated for non-metastatic colorectal cancer
Jeffery, M., Hickey, B. E., Hider, P. N., & See, A. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002200.pub3 · Cited by 640
Khatcheressian, J. L., Wolff, A. C., Smith, T. J., Grunfeld, E., Muss, H. B., Vogel, V. G., Halberg, F., Somerfield, M. R., & Davidson, N. E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8575 · Cited by 535
Serum Tumor Markers in Breast Cancer: Are They of Clinical Value?
Duffy, M. J. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.059832 · Cited by 460
Metadata
- Authors
- Moschetti, I., Cinquini, M., Lambertini, M., Levaggi, A., & Liberati, A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2016-05-27
- Volume
- 2016
- Issue
- 5
- Pages
- CD001768-CD001768
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2099882881
- Cited by
- 338
- References
- 39
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.